Author

Ayinde Yahaya

Observed institution: Mayo Clinic in Florida

OpenAlex ID: A5010567945

Abstract B046: Feasibility of patient-centered home care (PCHC) to reduce disparities in Black men (BM) with advanced prostate cancer (CaP): An iCCaRE Consortium for prostate cancer in Black men project

2023 · Roxana Dronca, Rohit Rao, et al. · Cancer Epidemiology Biomarkers & Prevention · 4

Abstract B050: The iCCARE consortium for prostate cancer in Black men: Grounded theory study of the social determinant of health factors among African immigrant men diagnosed with prostate cancer

2023 · Ernie Kaninjing, Gladys Asiedu, et al. · Cancer Epidemiology Biomarkers & Prevention · 2

Abstract A042: Addressing prostate cancer disparities through the Inclusive Cancer Care Research Equity (iCCaRE) for Black men consortium

2023 · Folakemi Odedina, Roxana Dronca, et al. · Cancer Epidemiology Biomarkers & Prevention · 2

Abstract B028: A point of prostate cancer diagnosis (PPCD) Virtual Robot Assistant (ViRA) intervention for newly diagnosed Black men: An iCCaRE consortium for prostate cancer in Black men project

2023 · Folakemi Odedina, Che Ngufor, et al. · Cancer Epidemiology Biomarkers & Prevention · 1

Abstract A045: Investigating the biological determinants of poor mental health among ethnically diverse Black prostate cancer survivors: An iCCaRE consortium for prostate cancer in Black men project

2023 · Solomon O. Rotimi, Folakemi Odedina, et al. · Cancer Epidemiology Biomarkers & Prevention · 1

Figure 5 from Advancing Prostate Cancer Survivorship through Transatlantic Consortium Science: The iCCaRE Initiative

2026 · Folakemi T. Odedina, Roxana Dronca, et al.

Supplementary Data from Advancing Prostate Cancer Survivorship through Transatlantic Consortium Science: The iCCaRE Initiative

2026 · Folakemi T. Odedina, Roxana Dronca, et al.

Table 2 from Advancing Prostate Cancer Survivorship through Transatlantic Consortium Science: The iCCaRE Initiative

2026 · Folakemi T. Odedina, Roxana Dronca, et al.

Table 1 from Advancing Prostate Cancer Survivorship through Transatlantic Consortium Science: The iCCaRE Initiative

2026 · Folakemi T. Odedina, Roxana Dronca, et al.

Figure 1 from Advancing Prostate Cancer Survivorship through Transatlantic Consortium Science: The iCCaRE Initiative

2026 · Folakemi T. Odedina, Roxana Dronca, et al.

Figure 4 from Advancing Prostate Cancer Survivorship through Transatlantic Consortium Science: The iCCaRE Initiative

2026 · Folakemi T. Odedina, Roxana Dronca, et al.

Figure 3 from Advancing Prostate Cancer Survivorship through Transatlantic Consortium Science: The iCCaRE Initiative

2026 · Folakemi T. Odedina, Roxana Dronca, et al.

Data from Advancing Prostate Cancer Survivorship through Transatlantic Consortium Science: The iCCaRE Initiative

2026 · Folakemi T. Odedina, Roxana Dronca, et al.

Figure 2 from Advancing Prostate Cancer Survivorship through Transatlantic Consortium Science: The iCCaRE Initiative

2026 · Folakemi T. Odedina, Roxana Dronca, et al.

Advancing Prostate Cancer Survivorship through Transatlantic Consortium Science: The iCCaRE Initiative

2026 · Folakemi T. Odedina, Roxana Dronca, et al. · Cancer Research Communications

Abstract 6289: Targeted sequencing of common cancer susceptibility genes reveals germline variants in African prostate cancer patients.

2026 · Abimbola F. Onyia, Freeman Okwuchi, et al. · Cancer Research

Abstract 818: Fighting prostate cancer with a multimedia approach

2024 · Vinessa Gordon, Folakemi Odedina, et al. · Cancer Research

Works count: 17

Citation count: 10

H-index: 2

I10-index: